Michki, Nigel S.
Singer, Benjamin D.
Perez, Javier V.
Thomas, Aaron J.
Natale, Valerie
Helmin, Kathryn A.
Wright, Jennifer
Cheng, Leon
Young, Lisa R.
Lederman, Howard M.
McGrath-Morrow, Sharon A. http://orcid.org/0000-0002-1576-5394
Funding for this research was provided by:
National Institutes of Health (R01HL114800, R01HL149883 R01HL153122 P01HL154998 P01AG049665 U19AI135964, K24HL143281)
U.S. Food and Drug Administration (R01FD007605, R01FD007605)
A-T Children's Project (A-T Children's Project)
Article History
Received: 23 October 2023
Accepted: 3 February 2024
First Online: 14 February 2024
Declarations
:
: The work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for studies involving humans. Participants were recruited from Johns Hopkins University and the Children’s Hospital of Philadelphia. This study was approved by the institutional review board of the Johns Hopkins Medical Institutions (IRB NA_00014314 and NA_00051764) and the institutional review board of the Children’s Hospital of Philadelphia (IRB 20-017524).
: Not applicable.
: BDS holds United States Patent No. US 10,905,706 B2, “Compositions and Methods to Accelerate Resolution of Acute Lung Inflammation”, and serves on the Scientific Advisory Board of Zoe Biosciences, outside of the submitted work. LRY provides authorship for UpToDate and serves on the pediatric advisory board for Boehringer Ingelheim, outside of the submitted work.